Radioiodine (131I) uptake in distant Metastases as a predicting factor of survival in differentiated thyroid carcinoma patients

被引：0
|
作者：
Mihailovic, J. [1 ]
Stefanovic, L. [1 ]
Malesevic, M. [1 ]
机构：
[1] Inst Oncol, Sremska Kamenica, Serbia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S231 / S231
页数：1
相关论文
共 50 条
  • [31] Improved Survival After Multimodal Approach with 131I Treatment in Patients with Bone Metastases Secondary to Differentiated Thyroid Cancer
    Wu, Di
    Lima, Cristiane J. Gomes
    Moreau, Shari L.
    Kulkarni, Kanchan
    Zeymo, Alexander
    Burman, Kenneth D.
    Wartofsky, Leonard
    Van Nostrand, Douglas
    THYROID, 2019, 29 (07) : 971 - 978
  • [32] The efficiency of planning of therapeutic 131I activities in the radioiodine therapy of differentiated thyroid cancer
    Sinyuta, B
    Dzhuzha, D
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1004 - 1004
  • [33] 131I Radiation Dose Distribution in Metastases of Thyroid Carcinoma
    Eterovic, Davor
    Markovic, Vinko
    Punda, Ante
    Antunovic, Zeljko
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (05) : 833 - 834
  • [34] Progression free survival related to 18F-FDG PET/CT uptake and 131I uptake in lung metastases of differentiated thyroid cancer
    Zhu, Xiaochun
    Wu, Shuqi
    Yuan, Xueyu
    Wang, Hui
    Ma, Chao
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2019, 22 (02): : 123 - 130
  • [35] Incremental Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma
    Chen, Libo
    Luo, Quanyong
    Shen, Yan
    Yu, Yongli
    Yuan, Zhibin
    Lu, Hankui
    Zhu, Ruisen
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (12) : 1952 - 1957
  • [36] 131I SPECT/CT in the Follow-Up of Patients With Differentiated Thyroid Carcinoma
    Menges, Mareen
    Uder, Michael
    Kuwert, Torsten
    Schmidt, Daniela
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (06) : 555 - 560
  • [37] Feasibility of 18F-FDG-guided surgery in the management of metastases from differentiated thyroid carcinoma with negative 131I uptake
    Cariou, B
    Mirallié, E
    Curtet, C
    Bridgi, B
    Rousseau, C
    Kraeber-Bodéré, F
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S327 - S327
  • [38] Curative Efficacy and Influencing Factors on 131I Treatment for Pulmonary Metastases from Differentiated Thyroid Carcinoma
    Xu, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S601 - S602
  • [39] Bone Marrow Function After 131I Therapy in Patients With Differentiated Thyroid Carcinoma
    Prinsen, Hester T.
    Hesselink, Esther N. Klein
    Brouwers, Adrienne H.
    Plukker, John T. M.
    Sluiter, Wim J.
    van der Horst-Schrivers, Anouk N. A.
    van Imhoff, Gustaaf W.
    Links, Thera P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (10): : 3911 - 3917
  • [40] Additional Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma
    Marini, I.
    Maussier, M.
    Perotti, G.
    Salvatori, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S72 - S72
12345